VanEck Associates’s Corpay CPAY Stock Holding History

VanEck Associates’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,859	Closed	-$4.13M	–	1465
2025 Q1	$4.13M	Buy	11,859 +221	+2%	+$79.8K	0.01%	780
2024 Q4	$3.94M	Buy	+11,638	New	+$4.09M	0.01%	777

Other funds holding CPAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

VanEck Associates's CPAY Position: Q2 2025 in Review

VanEck Associates sold out of Corpay (CPAY) in Q2 2025, closing a stake of 11,859 shares — an estimated $4.13M sold.

VanEck Associates first reported a position in CPAY in Q4 2024 and held it in 2 quarters. The position peaked at $4.13M in Q1 2025. 683 funds tracked by Wall St. Rank hold CPAY as of Q2 2025.

VanEck Associates reported no remaining Corpay position as of Q2 2025 after selling out during the quarter.
VanEck Associates sold 11,859 Corpay shares in Q2 2025, an estimated $4.13M.
VanEck Associates first reported a position in Corpay in Q4 2024 and held it in 2 quarters.
VanEck Associates's Corpay position peaked at $4.13M in Q1 2025.
683 funds tracked by Wall St. Rank held Corpay as of Q2 2025.

Based on VanEck Associates's 13F filing for Q2 2025, filed 14 Aug 2025.